ARTES Biotechnology issued New Patent in Australia for VLP Technology

ARTES Biotech­nol­o­gy spe­cial­ized in micro­bial cell line and process devel­op­ment as well as in tech­nol­o­gy trans­fer for phar­ma­ceu­ti­cal indus­try is pleased to announce the issuance of a new patent for their VLP plat­form. The patent will fur­ther strength­en the Metavax® plat­form of the com­pa­ny. In com­bi­na­tion with the expres­sion plat­form Hansenu­la Metavax® is a unique […]

New website!

ARTES has launched a new web­site, incor­po­rat­ing new con­tent to give a bet­ter view on the cur­rent busi­ness and added offer. The new site espe­cial­ly fea­tures an overview of ARTES’ busi­ness expan­sion in tech­nol­o­gy trans­fer and its Metavax® approach for VLP-based vac­cine devel­op­ment.

Strategic cooperation between ARTES Biotechnology and PAC

Artes and PAC join forces and com­bine their tech­nolo­gies and know-how. ARTES Biotech­nol­o­gy spe­cial­izes in recom­bi­nant pro­tein pro­duc­tion, process devel­op­ment in micro­bial expres­sion sys­tems and is a tech­nol­o­gy provider for phar­ma­ceu­ti­cal process­es, while PAC (Peschek Ana­lyt­ic Con­sult­ing) is high­ly skilled in the field of pro­tein analy­sis and qual­i­ty con­trol. Togeth­er with PAC, ARTES will now […]